hygromycin b has been researched along with thiazolyl blue in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, M; Kira, T; Merin, JP; Okamoto, T; Shigeta, S | 1 |
| Baba, M; Kira, T; Matsuyama, M; Merin, JP; Okamoto, T | 1 |
2 other study(ies) available for hygromycin b and thiazolyl blue
| Article | Year |
|---|---|
Anti-Tat MTT assay: a novel anti-HIV drug screening system using the viral regulatory network of replication.
Topics: Antiviral Agents; Base Sequence; Cell Line; Cinnamates; Colorimetry; Coloring Agents; DNA Primers; Drug Evaluation, Preclinical; Gene Products, tat; HIV-1; Humans; Hygromycin B; Molecular Sequence Data; tat Gene Products, Human Immunodeficiency Virus; Tetrazolium Salts; Thiazoles; Virus Replication | 1995 |
Alpha-lipoic acid blocks HIV-1 LTR-dependent expression of hygromycin resistance in THP-1 stable transformants.
Topics: Acetylcysteine; Antioxidants; Cell Line; Drug Resistance; Gene Expression Regulation, Viral; HIV Core Protein p24; HIV Long Terminal Repeat; HIV-1; Humans; Hygromycin B; Macrophages; NF-kappa B; Phosphotransferases (Alcohol Group Acceptor); Plasmids; Promoter Regions, Genetic; Tetrazolium Salts; Thiazoles; Thioctic Acid; Transfection; Tumor Necrosis Factor-alpha | 1996 |